Lataa...
Temsirolimus in the treatment of relapsed or refractory mantle cell lymphoma
Mantle cell lymphoma (MCL) is a rare and aggressive subtype of lymphoma associated with a poor prognosis. Chemotherapy is the mainstay of frontline treatment for patients with this disease. Despite high response rates to combination chemotherapy regimens, the majority of patients relapse within a fe...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2010
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2939769/ https://ncbi.nlm.nih.gov/pubmed/20856791 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|